Contact this trialFirst, we need to learn more about you.
Hallucinogen
Psilocybin for Depression in Alzheimer's
Recruiting1 awardPhase < 1
Baltimore, Maryland
This trial will test whether the hallucinogenic drug psilocybin is safe and effective for treating depression in people with Mild Cognitive Impairment or early Alzheimer's Disease.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.